VALVULAR AND STRUCTURAL HEART DISEASES Original Studies Predictors of Moderate-to-Severe Paravalvular Aortic Regurgitation Immediately After CoreValve Implantation and the Impact of Postdilatation

Objective: To investigate the predictors of moderate‐to‐severe aortic regurgitation (AR≥2+) after CoreValve implantation and evaluate the feasibility and safety of postdilatation in reducing the degree of AR. Background: Although transcatheter aortic valve implantation is an alternative treatment for high surgical risk patients with severe aortic stenosis, post‐implantation paravalvular AR remains a complication. Methods: From July 2008 to July 2010, we enrolled 79 consecutive patients with severe aortic stenosis who underwent CoreValve implantation. Results: On univariable analysis, the predictors of AR≥2+ immediately after CoreValve implantation were: larger annulus size, low implantation, prosthesis mismatch, chronic renal insufficiency, a history of heart failure, and peripheral vascular disease. On multivariable analysis, the independent predictors of AR≥2+ were: larger annulus diameter (OR 1.78, 95%CI 1.25–2.55; P = 0.002), low implantation (OR 3.67, 95%CI 1.01–13.35, P = 0.05), and peripheral vascular disease (OR 3.54, 95%CI 1.19–10.56, P = 0.02). Post‐CoreValve implantation, AR ≥ 2 was seen in 40.5% (32/79). Twenty‐one patients underwent postdilatation with improvement in AR grade in the majority (17/21). Of the four patients who did not respond to postdilatation, two underwent valve‐in‐valve implantation. In one patient, the valve was pulled more proximally by the snare technique. The remaining 10 patients were treated conservatively. Conclusion: The appropriate strategy for treating patients with AR≥2+ depends on the causes and severity of AR post‐TAVI. This study suggests that we should carefully select the size of CoreValve prosthesis to prevent prosthesis mismatch, especially when implanted in larger annulus sizes. For valves implanted in the appropriate position, postdilatation appears effective in reducing the degree of AR. © 2011 Wiley‐Liss, Inc.

[1]  Nikolaus Marx,et al.  Association of aortic valve calcification severity with the degree of aortic regurgitation after transcatheter aortic valve implantation. , 2011, International journal of cardiology.

[2]  H. Eggebrecht,et al.  Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. , 2011, European heart journal.

[3]  Robert Bauernschmitt,et al.  Aortic annulus evaluation in transcatheter aortic valve implantation , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  R. Tölg,et al.  Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. , 2010, Journal of the American College of Cardiology.

[5]  D. Capodanno,et al.  Management of implant failure during transcatheter aortic valve implantation , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6]  A. Vahanian,et al.  Transcatheter valve implantation for patients with aortic stenosis , 2010, Heart.

[7]  C. Tamburino,et al.  Consequences of underexpansion of a percutaneous aortic valve bioprosthesis. , 2010, The Journal of invasive cardiology.

[8]  R. Rajani,et al.  Paravalvular regurgitation one year after transcatheter aortic valve implantation , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[9]  O. Alfieri,et al.  A new technique for vascular access management in transcatheter aortic valve implantation , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  R. Hoffmann,et al.  Correction of CoreValve position using snare traction from a right brachial artery access. , 2010, The Journal of invasive cardiology.

[11]  G. Latsios,et al.  Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (in-series) CoreValve prostheses in 1 procedure. , 2010, JACC: Cardiovascular Interventions.

[12]  R. Schiele,et al.  Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology , 2010, Clinical Research in Cardiology.

[13]  J. Rodés‐Cabau,et al.  “Valve‐in‐valve” for the treatment of paravalvular leaks following transcatheter aortic valve implantation , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  Alec Vahanian,et al.  Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. , 2009, JACC. Cardiovascular interventions.

[15]  P. Serruys,et al.  Implantation of two self‐expanding aortic bioprosthetic valves during the same procedure—Insights into valve‐in‐valve implantation (“Russian doll concept”) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[16]  Zoran Bursac,et al.  Purposeful selection of variables in logistic regression , 2008, Source Code for Biology and Medicine.

[17]  T. Felderhoff,et al.  Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System , 2008, Circulation. Cardiovascular interventions.

[18]  P. Pibarot,et al.  Feasibility and initial results of percutaneous aortic valve implantation including selection of the transfemoral or transapical approach in patients with severe aortic stenosis. , 2008, The American journal of cardiology.

[19]  P. Serruys,et al.  Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[20]  Francesco Maisano,et al.  Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  N. Al-Attar,et al.  Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). , 2008, European heart journal.

[22]  Ghassan Sleilaty,et al.  Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. , 2008, Journal of the American College of Cardiology.

[23]  R. Moss,et al.  Role of echocardiography in percutaneous aortic valve implantation. , 2008, JACC. Cardiovascular imaging.

[24]  Mirko Doss,et al.  Transapical Minimally Invasive Aortic Valve Implantation: Multicenter Experience , 2007, Circulation.

[25]  Lukas Altwegg,et al.  Percutaneous Transarterial Aortic Valve Replacement in Selected High-Risk Patients With Aortic Stenosis , 2007, Circulation.

[26]  Thomas Walther,et al.  Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. , 2007, Journal of the American College of Cardiology.

[27]  A. Cribier,et al.  Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. , 2006, Journal of the American College of Cardiology.

[28]  P. Pibarot,et al.  Prosthesis-patient mismatch: definition, clinical impact, and prevention , 2005, Heart.

[29]  A. Fraser,et al.  Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography , 2003, Heart.

[30]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[31]  D. Malenka,et al.  Outcome of mild periprosthetic regurgitation detected by intraoperative transesophageal echocardiography. , 2001, Journal of the American College of Cardiology.

[32]  P. Pibarot,et al.  Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention. , 2000, Journal of the American College of Cardiology.

[33]  D. Hosmer,et al.  A comparison of goodness-of-fit tests for the logistic regression model. , 1997, Statistics in medicine.

[34]  N C Nanda,et al.  Evaluation of aortic insufficiency by Doppler color flow mapping. , 1987, Journal of the American College of Cardiology.

[35]  S. Rahimtoola,et al.  The problem of valve prosthesis-patient mismatch. , 1978, Circulation.